Intensive induction therapy with FLAG-idarubicin-venetoclax for fit older high-risk patients with acute myeloid leukemia

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-03-05
DOI
https://doi.org/10.3324/haematol.2025.300442
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intensive induction therapy with FLAG-idarubicin-venetoclax for fit older high-risk patients with acute myeloid leukemia

Baher Krayem, Israel Henig, Avraham Frisch, Dana Yehudai-Ofir et al.
Haematologica
Acute Myeloid Leukemia Research
article

Intensive induction therapy with FLAG-idarubicin-venetoclax for fit older high-risk patients with acute myeloid leukemia

Baher Krayem, Israel Henig, Avraham Frisch, Dana Yehudai-Ofir, Neta Glaubach, Tsila Zuckerman
article en

Abstract

No abstract available for this paper.
Haematologica
Memorial Sloan Kettering Cancer Center (US), Rambam Health Care Campus (IL), Rappaport Family Institute for Research in the Medical Sciences (IL)
Good health and well-being
Openalex Percentile: Top 32%
Acute Myeloid Leukemia Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.